Kobayashi Pharmaceutical Co., Ltd. (KBYPF)
39.47
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Kobayashi Pharmaceutical EPS Diluted (Quarterly) : 0.0084 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0084 |
| March 31, 2026 | 0.0888 |
| December 31, 2025 | -0.2753 |
| September 30, 2025 | 0.3323 |
| June 30, 2025 | 0.1436 |
| March 31, 2025 | 0.1433 |
| December 31, 2024 | 0.4169 |
| September 30, 2024 | 0.3523 |
| June 30, 2024 | 0.0397 |
| March 31, 2024 | 0.0884 |
| December 31, 2023 | 0.436 |
| September 30, 2023 | 0.6937 |
| June 30, 2023 | 0.4065 |
| March 31, 2023 | 0.3583 |
| December 31, 2022 | 0.5095 |
| September 30, 2022 | 0.6361 |
| June 30, 2022 | 0.4213 |
| March 31, 2022 | 0.3857 |
| December 31, 2021 | 0.5447 |
| September 30, 2021 | 0.8138 |
| June 30, 2021 | 0.4974 |
| March 31, 2021 | 0.4375 |
| December 31, 2020 | 0.4833 |
| September 30, 2020 | 0.8486 |
| June 30, 2020 | 0.5326 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.4393 |
| December 31, 2019 | 0.4583 |
| September 30, 2019 | 0.8395 |
| June 30, 2019 | 0.5239 |
| March 31, 2019 | 0.4235 |
| December 31, 2018 | 0.4773 |
| September 30, 2018 | 0.724 |
| June 30, 2018 | 0.4412 |
| March 31, 2018 | 0.4464 |
| December 31, 2017 | 0.4622 |
| September 30, 2017 | 0.5366 |
| June 30, 2017 | 0.4085 |
| March 31, 2017 | 0.3858 |
| December 31, 2016 | 0.7116 |
| September 30, 2016 | 0.3518 |
| June 30, 2016 | 0.6016 |
| March 31, 2016 | 0.5067 |
| March 31, 2015 | 0.183 |
| December 31, 2014 | 0.5599 |
| September 30, 2014 | 0.3587 |
| June 30, 2014 | 0.2896 |
| March 31, 2014 | 0.2446 |
| December 31, 2013 | 0.5225 |
| September 30, 2013 | 0.3691 |
| June 30, 2013 | 0.3666 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Medifast, Inc. | -0.2784 |
| Integrated BioPharma, Inc. | -0.044 |
| Kao Corp. | 0.0801 |
| Shiseido Co., Ltd. | 0.3348 |
| Skinvisible, Inc. | -0.0473 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.6338M |
| Revenue (Quarterly) | 232.72M |
| Total Expenses (Quarterly) | 232.08M |
| Enterprise Value | 2.586B |
| Gross Profit Margin (Quarterly) | 49.95% |
| Profit Margin (Quarterly) | 0.27% |
| Earnings Yield | 0.39% |
| Operating Earnings Yield | 2.35% |
| Normalized Earnings Yield | 2.942 |